Literature DB >> 8627186

Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.

H W Snoeck1, S Weekx, A Moulijn, F Lardon, M Lenjou, G Nys, P C Van Ranst, D R Van Bockstaele, Z N Berneman.   

Abstract

Since tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, and transforming growth factor (TGF)-beta have all been shown to be specific inhibitors of early human hematopoiesis, we wanted to investigate the interactions of these three cytokines on very primitive human adult bone marrow CD34++CD38- hematopoietic progenitor cells, using a pre-colony-forming cell (pre-CFC) assay, which detects the effects of these cytokines on the initial phases of the differentiation of these primitive progenitors, which are unresponsive to interleukin (IL) 3 alone. Surprisingly, TNF-alpha was a very potent stimulator of the proliferation of CD34++CD38- cells and was the most potent synergistic factor for the IL-3-induced proliferation of these cells of all cytokines tested (IL-1, IL-6, granulocyte colony-stimulating factor, kit ligand). TNF-alpha was the only cytokine that, as a single added factor, induced substantial proliferation in CD34++CD38- cells in the presence of IL-3, except for kit ligand, which induced very limited proliferation. TNF-alpha, moreover, induced a high degree of resistance to the inhibitory effects of TGF-beta in a dose-dependent way. The inhibitory effects of IFN-gamma, however, were not affected by the presence of TNF-alpha. We hypothesize that in situations of the hematopoietic stress, TNF-alpha may abrogate the inhibitory effect of ambient TGF-beta in the bone marrow microenvironment to allow primitive stem cells to proliferate and differentiate in response to an increased demand for mature blood cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627186      PMCID: PMC2192448          DOI: 10.1084/jem.183.2.705

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Net increase of pluripotential hematopoietic precursors in suspension culture in response to IL-1 and IL-3.

Authors:  N N Iscove; A R Shaw; G Keller
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

2.  The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.

Authors:  H E Broxmeyer; D E Williams; L Lu; S Cooper; S L Anderson; G S Beyer; R Hoffman; B Y Rubin
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

3.  Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer.

Authors:  C J Eaves; J D Cashman; R J Kay; G J Dougherty; T Otsuka; L A Gaboury; D E Hogge; P M Lansdorp; A C Eaves; R K Humphries
Journal:  Blood       Date:  1991-07-01       Impact factor: 22.113

4.  Potentiation of early hematopoiesis by tumor necrosis factor-alpha is followed by inhibition of granulopoietic differentiation and proliferation.

Authors:  C Caux; C Favre; S Saeland; V Duvert; I Durand; P Mannoni; J Banchereau
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

5.  Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.

Authors:  L W Terstappen; S Huang; M Safford; P M Lansdorp; M R Loken
Journal:  Blood       Date:  1991-03-15       Impact factor: 22.113

6.  TNF-alpha inhibits the further development of committed progenitors while stimulating multipotential progenitors in mouse long-term bone marrow cultures.

Authors:  J A Rogers; J W Berman
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

7.  Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation.

Authors:  J R Keller; I K Mcniece; K T Sill; L R Ellingsworth; P J Quesenberry; G K Sing; F W Ruscetti
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

8.  Functional isolation and characterization of human hematopoietic stem cells.

Authors:  A C Berardi; A Wang; J D Levine; P Lopez; D T Scadden
Journal:  Science       Date:  1995-01-06       Impact factor: 47.728

9.  Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.

Authors:  J R Keller; S E Jacobsen; K T Sill; L R Ellingsworth; F W Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

10.  Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides.

Authors:  J Hatzfeld; M L Li; E L Brown; H Sookdeo; J P Levesque; T O'Toole; C Gurney; S C Clark; A Hatzfeld
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  11 in total

1.  Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells.

Authors:  I Plo; D Lautier; T Levade; H Sekouri; J P Jaffrézou; G Laurent; A Bettaïeb
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.

Authors:  M Bitzer; G von Gersdorff; D Liang; A Dominguez-Rosales; A A Beg; M Rojkind; E P Böttinger
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

3.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Authors:  Sara L Montgomery; Michael A Mastrangelo; Diala Habib; Wade C Narrow; Sara A Knowlden; Terry W Wright; William J Bowers
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

Review 4.  Mesenchymal stromal cells as supportive cells for hepatocytes.

Authors:  Alejandro Gómez-Aristizábal; Armand Keating; John E Davies
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

5.  The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors.

Authors:  Masahiro Masuya; Naoyuki Katayama; Natsuki Hoshino; Hiroyoshi Nishikawa; Seiji Sakano; Hiroto Araki; Hidetsugu Mitani; Hirohito Suzuki; Hiroyuki Miyashita; Kyoko Kobayashi; Kazuhiro Nishii; Nobuyuki Minami; Hiroshi Shiku
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

6.  Thermal injury induces the development of inflammatory macrophages from nonadherent bone marrow cells.

Authors:  C K Ogle; J F Valente; X Guo; B G Li; J D Ogle; J W Alexander
Journal:  Inflammation       Date:  1997-12       Impact factor: 4.092

7.  Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line.

Authors:  Erian H Girgis; John P Mahoney; Rafaat H Khalil; Magdi R Soliman
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

8.  Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes.

Authors:  Senji Kasahara; Kazuki Ando; Kuniaki Saito; Kenji Sekikawa; Hiroyasu Ito; Tetsuya Ishikawa; Hiroo Ohnishi; Mitsuru Seishima; Shinichi Kakumu; Hisataka Moriwaki
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level.

Authors:  V I Rebel; S Hartnett; G R Hill; S B Lazo-Kallanian; J L Ferrara; C A Sieff
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

10.  Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferation.

Authors:  Paolo Gallipoli; Francesca Pellicano; Heather Morrison; Kamilla Laidlaw; Elaine K Allan; Ravi Bhatia; Mhairi Copland; Heather G Jørgensen; Tessa L Holyoake
Journal:  Blood       Date:  2013-09-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.